<p><em>Conference Reporter </em>delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. <em>Conference Reporter</em> will feature community-selected experts and topics in HR+ HER2- Breast Cancer presented at this year’s ASCO Meeting.</p>

---

VIEW THE TOPICS

• Advances in the Treatment of HR2+/HER2- Breast Cancer
• HR+/HER2- Breast Cancer and the Problem of Resistance to Endocrine Therapies
• Identifying Candidates for Neoadjuvant or Adjuvant Anti-Her2 Therapy
• Importance of Next-Generation Sequencing in Guiding Therapy Selection
• Second-line Treatment for Advanced/Metastatic HR+/HER2- Breast Cancer
• The Role of Predictive Biomarkers for Patients With HR+ Breast Cancer

 

 

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.